Overview
Today delivered 59 continuation breakout signals, marking a robust day for momentum-driven opportunities. The quality appears mixed but compelling, with several high-conviction setups emerging from energy, biotech, and medical sectors. Notable strength indicators include SOC’s explosive 15.1% move on 3.2x relative volume and DTCX’s impressive 13.2% gain with 1.7x RVOL. The diversity across sectors—from energy to healthcare to retail—suggests broad-based momentum rather than sector-specific rotation.
Top 5 Picks
SOC ($16.58) — Energy/Oil&Gas-Integrated
Technical Setup: SOC presents the most compelling breakout signal today with a massive 15.1% surge on 3.2x relative volume and positive ATR momentum (+6.8%). Currently positioned between key zones, the stock has substantial room to run toward the $18.39-$20.74 supply zone. The 8.4 strength demand zone at $13.92-$14.41 provides excellent downside support.
| Level | Price | Notes |
|---|---|---|
| Entry | $16.50-$16.70 | Current breakout zone |
| Stop Loss | $14.25 | Below demand zone |
| Target | $18.50 | Supply zone approach |
Institutional Backing: 209 funds provide solid institutional support for this energy play.
DTCX ($3.00) — Financial/Financial Data & Stock Exchanges
Technical Setup: This financial services play shows exceptional momentum with 13.2% gains on 1.7x volume. Positioned between zones with immediate supply resistance at $3.11. The daily demand zone at $2.42-$2.67 sits well below current levels, indicating strong upside momentum continuation potential.
| Level | Price | Notes |
|---|---|---|
| Entry | $2.95-$3.05 | Above supply break |
| Stop Loss | $2.65 | Demand zone protection |
| Target | $3.35 | Next resistance level |
Institutional Backing: 11 funds—limited but focused institutional interest.
MEDP ($477.72) — Medical/Medical-Research Equipment
Technical Setup: MEDP offers a lower-risk continuation play with solid 2.3% gains from a strong demand zone. The daily demand at $460-$470.59 provides excellent support, while the distant supply zone at $530-$547 offers significant upside potential. Lower volatility (73.4% ATR risk) makes this ideal for conservative momentum traders.
| Level | Price | Notes |
|---|---|---|
| Entry | $475-$480 | Demand zone breakout |
| Stop Loss | $455 | Below demand support |
| Target | $520 | Toward supply zone |
Institutional Backing: Exceptional support with 958 funds—highest institutional coverage in today’s list.
CNTX ($3.17) — Healthcare/Biotechnology
Technical Setup: This biotech breakout shows strong momentum with 8.6% gains and 1.1x relative volume. Trading at demand with no immediate supply overhead creates an attractive risk/reward setup. The 1-hour demand zone at $2.93-$3.10 provides tight stop placement.
| Level | Price | Notes |
|---|---|---|
| Entry | $3.15-$3.25 | Above demand break |
| Stop Loss | $2.85 | Below demand zone |
| Target | $3.75 | Open upside target |
Institutional Backing: 27 funds—moderate institutional interest typical for biotech.
LXU ($13.50) — Agriculture/Chemicals-Agricultural
Technical Setup: LXU presents a supply zone test with 5.9% gains on exceptional 2.1x volume. Currently at supply resistance, but strong momentum and B2 bucket classification suggest potential breakout continuation. The weekly supply zone at $13.90-$14.71 represents the key battle zone.
| Level | Price | Notes |
|---|---|---|
| Entry | $13.45-$13.60 | Supply zone hold |
| Stop Loss | $12.65 | Below demand support |
| Target | $14.85 | Above supply break |
Institutional Backing: 200 funds with B2 classification indicating solid institutional framework.
Honorable Mentions
- CABO ($114.41): Telecom surge +11.1% on 1.7x volume, testing supply at $115-$117
- MUSA ($444.91): Retail momentum +2.2% at supply resistance with 607 fund backing
- TECX ($34.79): Biotech continuation +4.7% between zones with 141 institutional holders
- TNGX ($16.99): Medical play +3.0% between zones, 218 funds supporting
- BRCB ($16.71): Beverage sector +4.2% at demand with 180 institutional funds
Strategy Summary
Today’s continuation breakouts offer exceptional quality across multiple timeframes and sectors. Energy leads with SOC’s explosive move, while medical and biotech sectors provide multiple opportunities. The mix of high-momentum plays (SOC, DTCX) and steady institutional favorites (MEDP) creates diverse portfolio options. Risk management remains crucial given the elevated ATR levels, but the strong volume confirmation and institutional backing across most picks suggest sustainable momentum. Focus on the energy and healthcare sectors for the highest probability setups.